Skip to main content
HealthReportedMediumDeveloping
5.2

Brazil's Anvisa seizes counterfeit botulinum toxin batch, bans sale and use

Brazil's health regulator Anvisa ordered seizure of a counterfeit batch of botulinum toxin, prohibiting sale, distribution, or use. The action follows detection of a fake product in the market, posing potential health risks. The scope of distribution and any reported adverse effects remain unclear.

Poder3601 day agoBRCredibility 40%View source

Score Breakdown

Mosaic Score5.2
Model confidence0.7
Significance0.5
Source credibility0.4
Source

Related signals

8 found